Several studies that aim to define the role of EPO treatment in CHF, in the combination of CHF and CKD, and in acute myocardial infarction, are underway. Several mechanisms for resistance to ...

Clin Lipidology. 2011;6(6):693-702. The association between CKD and CVD is complex and multifactorial. Traditional risk factors such as hypertension, diabetes and dyslipidemia that predispose the ...

ACR: Albumin:creatinine ratio; CVD: Cardiovascular disease ... Para-aminohippurate (marker of renal plasma flow). Reproduced with kind permission from Springer Science and Business Media [9].

New research funding will investigate the early stages of heart disease associated ... Foundation to understand the mechanisms driving the early stages of CKD-associated cardiomyopathy.